MicroRNA-31 promotes adverse cardiac remodeling and dysfunction in ischemic heart disease
Eliana C. Martinez(University of Miami), Mark Richards(National University Health System), Shera Lilyanna(National University of Singapore), Leah A. Vardy(Agency for Science, Technology and Research), Kandiah Jeyaseelan(National University of Singapore), Peipei Wang(Jinan University), Xiaofei Jiang(Zhuhai People's Hospital), Arunmozhiarasi Armugam(National University of Singapore)
Cited by 56
Related Papers
Heart Failure Association of the European Society of Cardiology Practical Guidance on the Use of Natriuretic Peptide Concentrations
|European Journal of Heart Failure|2019|786
Evolution of virulence in epidemic community-associated methicillin-resistant <i>Staphylococcus aureus</i>
|Proceedings of the National Academy of Sciences|2009|397
Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005–2014
|Clinical Microbiology and Infection|2016|376
Plasma B-type natriuretic peptide levels in systolic heart failure
|Journal of the American College of Cardiology|2004|272